A detailed history of Inceptionr LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Inceptionr LLC holds 428 shares of LLY stock, worth $353,703. This represents 0.08% of its overall portfolio holdings.

Number of Shares
428
Previous 1,451 70.5%
Holding current value
$353,703
Previous $1.2 Billion 72.16%
% of portfolio
0.08%
Previous 0.36%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$713.71 - $898.95 $730,125 - $919,625
-1,023 Reduced 70.5%
428 $334 Million
Q1 2025

May 12, 2025

BUY
$725.72 - $929.72 $388,985 - $498,329
536 Added 58.58%
1,451 $1.2 Billion
Q4 2024

Feb 06, 2025

BUY
$727.2 - $932.06 $94,536 - $121,167
130 Added 16.56%
915 $706 Million
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $606,129 - $753,615
785 New
785 $695 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $1.1 Million - $1.29 Million
3,529 New
3,529 $1.21 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $785B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.